Increased Free Water in the Substantia Nigra in Asymptomatic LRRK2 G2019S Mutation Carriers

被引:4
|
作者
Zhang, Dongling [1 ,2 ,3 ]
Zhou, Liche [4 ]
Shi, Yuting [5 ]
Liu, Jun
Wei, Hongjiang [5 ]
Tong, Qiqi [6 ]
He, Hongjian [7 ]
Wu, Tao [1 ,2 ,3 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Ctr Movement Disorders, Beijing, Peoples R China
[2] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing, Peoples R China
[4] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Neurol & Inst Neurol, Sch Med, Shanghai, Peoples R China
[5] Shanghai Jiao Tong Univ, Inst Med Imaging Technol, Sch Biomed Engn, Shanghai, Peoples R China
[6] Zhejiang Lab, Res Ctr Healthcare Data Sci, Hangzhou, Zhejiang, Peoples R China
[7] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Ctr Brain Imaging Sci & Technol, Hangzhou, Zhejiang, Peoples R China
基金
国家重点研发计划; 美国国家卫生研究院; 中国国家自然科学基金;
关键词
leucine-rich repeat kinase 2; free water; biomarker; posterior substantia nigra; PARKINSONS-DISEASE; MULTISITE; ELIMINATION; BRAIN;
D O I
10.1002/mds.29253
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The alteration of substantia nigra (SN) degeneration in populations at risk of Parkinson's disease (PD) is unclear. Objective: We investigated free water (FW) values in the posterior SN (pSN) in asymptomatic LRRK2 G2019S mutation carriers. Methods: We analyzed diffusion imaging data from 28 asymptomatic LRRK2 G2019S mutation carriers and 30 healthy controls (HCs), whereas 11 asymptomatic LRRK2 G2019S carriers and 11 HCs were followed up. FW values in the pSN were measured and compared between the groups. The relationship between longitudinal changes in FW in the pSN and dopamine transporter striatal binding ratio (SBR) was analyzed. Results: FW values in the pSN were significantly elevated and kept increasing during follow-up in asymptomatic LRRK2 G2019S carriers. There was a negative correlation between FW changes in the left pSN and SBR changes in the left putamen. Conclusion: FW in the pSN has the potential to be a progression imaging marker of early dopaminergic degeneration in the population at risk of PD. (c) 2022 International Parkinson and Movement Disorder Society.
引用
收藏
页码:138 / 142
页数:5
相关论文
共 50 条
  • [1] Substantia Nigra Hyperechogenicity with LRRK2 G2019S Mutations
    Brueggemann, Norbert
    Hagenah, Johann
    Stanley, Kaili
    Klein, Christine
    Wang, Cuiling
    Raymond, Deborah
    Ozelius, Laurie
    Bressman, Susan
    Saunders-Pullman, Rachel
    MOVEMENT DISORDERS, 2011, 26 (05) : 885 - 888
  • [2] Gait Alterations in Healthy Carriers of the LRRK2 G2019S Mutation
    Mirelman, Anat
    Gurevich, Tanya
    Giladi, Nir
    Bar-Shira, Anat
    Orr-Urtreger, Avi
    Hausdorff, Jeffrey M.
    ANNALS OF NEUROLOGY, 2011, 69 (01) : 193 - 197
  • [3] Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriers
    Thaler, Avner
    Mirelman, Anat
    Helmich, Rick C.
    van Nuenen, Bart F. L.
    Rosenberg-Katz, Keren
    Gurevich, Tanya
    Orr-Urtreger, Avi
    Marder, Karen
    Bressman, Susan
    Bloem, Bastiaan R.
    Giladi, Nir
    Hendler, Talma
    CORTEX, 2013, 49 (09) : 2501 - 2511
  • [4] Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers
    Vilas, Dolores
    Ispierto, Lourdes
    Alvarez, Ramiro
    Pont-Sunyer, Claustre
    Jose Marti, Maria
    Valldeoriola, Francesc
    Compta, Yaroslau
    de Fabregues, Oriol
    Hernandez-Vara, Jorge
    Puente, Victor
    Calopa, Matilde
    Jauma, Serge
    Campdelacreu, Jaume
    Aguilar, Miquel
    Quilez, Pilar
    Casquero, Pilar
    Lomena, Francisco
    Rios, Jose
    Tolosa, Eduardo
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (10) : 1170 - 1176
  • [5] Increased Phospho-AKT in Blood Cells from LRRK2 G2019S Mutation Carriers
    Garrido, Alicia
    Perez-Sisques, Leticia
    Simonet, Cristina
    Campoy-Campos, Genis
    Solana-Balaguer, Julia
    Martin-Flores, Nuria
    Fernandez, Manel
    Soto, Marta
    Obiang, Donina
    Camara, Ana
    Valldeoriola, Francesc
    Munoz, Esteban
    Compta, Yaroslau
    Perez-Navarro, Esther
    Alberch, Jordi
    Tolosa, Eduardo
    Marti, Maria-Jose
    Ezquerra, Mario
    Malagelada, Cristina
    Fernandez-Santiago, Ruben
    ANNALS OF NEUROLOGY, 2022, 92 (05) : 888 - 894
  • [6] Exercise knowledge, barriers and motivators among LRRK2 G2019S mutation carriers
    Schootemeijer, S.
    Coker, D.
    Shelton, J. F.
    Chanoff, E.
    Rowbotham, H. M.
    Darweesh, S. K. L.
    Bloem, B. R.
    Cannon, P.
    de Vries, N. M.
    PARKINSONISM & RELATED DISORDERS, 2023, 113
  • [7] DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers
    Artzi, Moran
    Even-Sapir, Einat
    Shacham, Hedva Lerman
    Thaler, Avner
    Urterger, Avi Orr
    Bressman, Susan
    Marder, Karen
    Hendler, Talma
    Giladi, Nir
    Ben Bashat, Dafna
    Mirelman, Anat
    PLOS ONE, 2017, 12 (04):
  • [8] Nonmotor Symptoms in Healthy Ashkenazi Jewish Carriers of the G2019S Mutation in the LRRK2 Gene
    Mirelman, Anat
    Alcalay, Roy N.
    Pullman, Rachel Saunders
    Yasinovsky, Kira
    Thaler, Avner
    Gurevich, Tanya
    Melia-Santana, Helen
    Raymond, Deborah
    Gana-Weisz, Mali
    Bar-Shira, Anat
    Ozelius, Laurie
    Clark, Lorraine
    Orr-Urtreger, Avi
    Bressman, Susan
    Marder, Karen
    Giladi, Nir
    MOVEMENT DISORDERS, 2015, 30 (07) : 981 - 986
  • [9] Reorganization of corticostriatal circuits in healthy G2019S LRRK2 carriers
    Helmich, Rick C.
    Thaler, Avner
    van Nuenen, Bart F. L.
    Gurevich, Tanya
    Mirelman, Anat
    Marder, Karen S.
    Bressman, Susan
    Orr-Urtreger, Avi
    Giladi, Nir
    Bloem, Bastiaan R.
    Toni, Ivan
    NEUROLOGY, 2015, 84 (04) : 399 - 406
  • [10] Frequency of the LRRK2 G2019S mutation in siblings with Parkinson's disease
    Lesage, Suzanne
    Leclere, Laurence
    Lohmann, Ebba
    Borg, Michel
    Ruberg, Merle
    Duerr, Alexandra
    Brice, Alexis
    NEURODEGENERATIVE DISEASES, 2007, 4 (2-3) : 195 - 198